Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04812197 · ClinicalTrials.gov registry record · NA
Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced Dermatitis
A NA study, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04812197 is a NA study that has completed, run by City of Hope Medical Center. The registered enrollment target is 2 participants.
The verdict
NCT04812197, a NA study, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study determines microbial diversity between inflamed and non-inflamed skin of patients with immune checkpoint inhibitor-induced dermatitis. Skin has millions of bacteria. When treated with an immunotherapy agent, skin issues like a rash are common, occurring in up to 45% of patients. This study finds out if the type of bacteria on skin is different between the affected and unaffected skin in patients who have this treatment-related rash and also compares the immune cells found in the skin tissue to those seen in the blood.
Interventions
- PROCEDURE Biospecimen Collection(Punch Biopsy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2021-10-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04812197
The ClinicalTrials.gov registry entry for NCT04812197 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biospecimen Collection(Punch Biopsy) is the first listed.
NCT04812197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04812197 about?
NCT04812197 is a clinical study titled "Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced Dermatitis". This study determines microbial diversity between inflamed and non-inflamed skin of patients with immune checkpoint inhibitor-induced dermatitis. Skin has millions of bacteria. When treated with an immunotherapy agent, skin issues like a rash are common, occurring in up to 45% of patients. This stud...
What is the current status of trial NCT04812197?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2021-03-08. Estimated completion is 2021-10-08.
What interventions are being tested in trial NCT04812197?
The interventions under investigation include: Biospecimen Collection(Punch Biopsy) (PROCEDURE).
Who is sponsoring clinical trial NCT04812197?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.